Cutting Edge: ST8Sia6-Generated α-2,8-Disialic Acids Mitigate Hyperglycemia in Multiple Low-Dose Streptozotocin–Induced Diabetes
- 15 June 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (12) , 3071-3076
Abstract
The immune system contains a series of checks and balances that maintain tolerance and prevent autoimmunity. Sialic acid-binding Ig-type lectins (Siglecs) are cell surface receptors found on immune cells and inhibit inflammation by recruiting protein tyrosine phosphatases to ITIMs. Islet-resident macrophages express Siglec-E, and Siglec-E expression decreases on islet-resident macrophages as insulitis progresses in the NOD mouse. The sialyltransferase ST8Sia6 generates α-2,8-disialic acids that are ligands for Siglec-E in vivo. We hypothesized that engaging Siglec-E through ST8Sia6-generated ligands may inhibit the development of immune-mediated diabetes. Constitutive overexpression of ST8Sia6 in pancreatic β cells mitigated hyperglycemia in the multiple low-dose streptozotocin model of diabetes, demonstrating that engagement of this immune receptor facilitates tolerance in the setting of inflammation and autoimmune disease.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases, National Institutes of Health (R21AI138858-01A1)
- Mayo Clinic Wilbur T. and Grace C. Pobanz Predoctoral Fellowship
This publication has 22 references indexed in Scilit:
- Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapyNature Medicine, 2019
- Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD miceProceedings of the National Academy of Sciences, 2017
- The islet-resident macrophage is in an inflammatory state and senses microbial products in bloodJournal of Experimental Medicine, 2017
- Targeting Siglecs with a sialic acid–decorated nanoparticle abrogates inflammationScience Translational Medicine, 2015
- Siglec-mediated regulation of immune cell function in diseaseNature Reviews Immunology, 2014
- Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancerProceedings of the National Academy of Sciences, 2014
- Defining the Transcriptional and Cellular Landscape of Type 1 Diabetes in the NOD MousePLOS ONE, 2013
- Islet Autoantigens: Structure, Function, Localization, and RegulationCold Spring Harbor Perspectives in Medicine, 2012
- The murine inhibitory receptor mSiglec‐E is expressed broadly on cells of the innate immune system whereas mSiglec‐F is restricted to eosinophilsEuropean Journal of Immunology, 2004
- Molecular Cloning and Expression of a Sixth Type of α2,8-Sialyltransferase (ST8Sia VI) That SialylatesO-GlycansJournal of Biological Chemistry, 2002